DMS Stock Swiss Exchange
Equities
OXDGM
FR0000063224
Advanced Medical Equipment & Technology
Sales 2021 | 39.99M 42.83M 58.8M | Sales 2022 | 37.06M 39.69M 54.49M | Capitalization | 16.28M 17.44M 23.94M |
---|---|---|---|---|---|
Net income 2021 | -3M -3.21M -4.41M | Net income 2022 | -6M -6.43M -8.82M | EV / Sales 2021 | 0.78 x |
Net Debt 2021 | 11.67M 12.5M 17.16M | Net Debt 2022 | 10.98M 11.76M 16.14M | EV / Sales 2022 | 0.74 x |
P/E ratio 2021 |
-5.08
x | P/E ratio 2022 |
-2.39
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 81.58% |
Managers | Title | Age | Since |
---|---|---|---|
Samuel Sancerni
CHM | Chairman | - | 11-09-26 |
Léone Atayi
BRD | Director/Board Member | - | - |
Nawel Naamane
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Samuel Sancerni
CHM | Chairman | - | 11-09-26 |
Regis Roche
BRD | Director/Board Member | - | - |
Léone Atayi
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
-3.25% | 15.01B | |
-38.91% | 2.8B | |
-12.68% | 2.45B | |
-12.18% | 1.46B | |
-.--% | 1.12B | |
+43.80% | 518M | |
+92.56% | 505M | |
+14.23% | 245M | |
-19.37% | 183M |